These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32794555)

  • 1. Biomarkers for Disease Severity in Children Infected With Respiratory Syncytial Virus: A Systematic Literature Review.
    Öner D; Drysdale SB; McPherson C; Lin GL; Janet S; Broad J; Pollard AJ; Aerssens J;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S648-S657. PubMed ID: 32794555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological and Inflammatory Biomarkers of Susceptibility and Severity in Adult Respiratory Syncytial Virus Infections.
    Wiseman DJ; Thwaites RS; Drysdale SB; Janet S; Donaldson GC; Wedzicha JA; Openshaw PJ;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S584-S591. PubMed ID: 32227102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).
    Jefferies K; Drysdale SB; Robinson H; Clutterbuck EA; Blackwell L; McGinley J; Lin GL; Galal U; Nair H; Aerssens J; Öner D; Langedijk A; Bont L; Wildenbeest JG; Martinon-Torres F; Rodríguez-Tenreiro Sánchez C; Nadel S; Openshaw P; Thwaites R; Widjojoatmodjo M; Zhang L; Nguyen TL; Giaquinto C; Giordano G; Baraldi E; Pollard AJ;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S658-S665. PubMed ID: 32794560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.
    Moe N; Krokstad S; Stenseng IH; Christensen A; Skanke LH; Risnes KR; Nordbø SA; Døllner H
    PLoS One; 2017; 12(1):e0170200. PubMed ID: 28095451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection.
    Mejias A; Dimo B; Suarez NM; Garcia C; Suarez-Arrabal MC; Jartti T; Blankenship D; Jordan-Villegas A; Ardura MI; Xu Z; Banchereau J; Chaussabel D; Ramilo O
    PLoS Med; 2013 Nov; 10(11):e1001549. PubMed ID: 24265599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children.
    Englund JA; Cohen RA; Bianco V; Domachowske JB; Langley JM; Madhi SA; Zaman K; Bueso A; Ceballos A; Cousin L; Gandhi S; Gruselle O; Jose L; Klein NP; Koen A; Puthanakit T; Shi M; Silas P; Tangsathapornpong A; Teeratakulpisarn J; Vesikari T; Haars G; Leach A; Stoszek SK; Dieussaert I
    J Pediatric Infect Dis Soc; 2023 May; 12(5):273-281. PubMed ID: 37142551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines.
    Ueno F; Tamaki R; Saito M; Okamoto M; Saito-Obata M; Kamigaki T; Suzuki A; Segubre-Mercado E; Aloyon HD; Tallo V; Lupisan SP; Oshitani H;
    Influenza Other Respir Viruses; 2019 Jul; 13(4):339-353. PubMed ID: 30891896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review.
    Bylsma LC; Suh M; Movva N; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S267-S281. PubMed ID: 35968871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RSV-CLASS -Clinical Assessment Severity Score: An easy-to-use clinical disease severity score for respiratory syncytial virus infection in hospitalized children.
    Gsenger J; Bruckner T; Ihling CM; Rehbein RM; Schnee SV; Hoos J; Manuel B; Pfeil J; Schnitzler P; Tabatabai J
    J Med Virol; 2023 Feb; 95(2):e28541. PubMed ID: 36727642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age.
    Movva N; Suh M; Bylsma LC; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S213-S224. PubMed ID: 35968874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome.
    Fonseca W; Lukacs NW; Ptaschinski C
    Front Immunol; 2018; 9():226. PubMed ID: 29515570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and epidemiological impact of respiratory syncytial virus and identification of risk factors for severe disease in children hospitalized due to acute respiratory tract infection.
    Ferolla FM; Soffe J; Mistchenko A; Contrini MM; López EL
    Arch Argent Pediatr; 2019 Aug; 117(4):216-223. PubMed ID: 31339263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1.
    Pierangeli A; Viscido A; Bitossi C; Frasca F; Gentile M; Oliveto G; Frassanito A; Nenna R; Midulla F; Scagnolari C
    Med Microbiol Immunol; 2020 Feb; 209(1):23-28. PubMed ID: 31485724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
    Wildenbeest JG; Zuurbier RP; Korsten K; van Houten MA; Billard MN; Derksen-Lazet N; Snape MD; Drysdale SB; Robinson H; Pollard AJ; Heikkinen T; Cunningham S; Leach A; Martinón-Torres F; Rodríguez-Tenreiro Sánchez C; Gómez-Carballa A; Bont LJ;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S606-S612. PubMed ID: 32794574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, risk factors and clinical characteristics of respiratory syncytial virus-associated lower respiratory tract infections in Kelantan, Malaysia.
    Teck KS; Mac Guad R; Van Rostenberghe AH; Hua GS
    J Med Virol; 2019 Sep; 91(9):1608-1615. PubMed ID: 31074499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants.
    Zomer-Kooijker K; Uiterwaal CS; van der Gugten AC; Wilbrink B; Bont LJ; van der Ent CK
    Eur Respir J; 2014 Sep; 44(3):666-74. PubMed ID: 24993909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function sequelae after respiratory syncytial virus lower respiratory tract infection in children: A systematic review.
    Verwey C; Nunes MC; Dangor Z; Madhi SA
    Pediatr Pulmonol; 2020 Jul; 55(7):1567-1583. PubMed ID: 32364320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid weight gain in early life is associated with severity of respiratory syncytial virus (RSV) bronchiolitis in children.
    Kim YR; Cho HK; Lee EH; Choi YS; Yoon HS; Han MY; Rha YH; Jung HW
    Allergol Immunopathol (Madr); 2021; 49(2):23-30. PubMed ID: 33641290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-endothelial interactions in respiratory syncytial virus bronchiolitis: An understudied aspect with a potential for prediction of severity of disease.
    Juliana A; Zonneveld R; Plötz FB; van Meurs M; Wilschut J
    J Clin Virol; 2020 Feb; 123():104258. PubMed ID: 31931445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.